In this review, we will present the current data on commercially available molecular profiling assays in breast cancer and discuss the challenges surrounding their incorporation into routine clinical practice as prognostic and predictive tools.
Yesim Gökmen-polar, PhD
Advertisement
Articles by Yesim Gökmen-polar, PhD
Advertisement
Latest Updated Articles
- Molecular Profiling Assays in Breast Cancer: Are We Ready for Prime Time?
Published: April 15th 2012 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
FDA Clears IND Application for Novel IL-2 Agent in Advanced NSCLC
2
Lifileucel Confers Durable Responses in Pretreated Advanced NSCLC Type
3
Novel TLR Coagonist Combo Shows Responses in Stage IV NSCLC
4
Glofitamab/Polatuzumab Vedotin Exhibits Response Durability in R/R LBCL
5
